Organogenesis Holdings (ORGO) Gains from Investment Securities: 2016-2024
Historic Gains from Investment Securities for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $10.6 million.
- Organogenesis Holdings' Gains from Investment Securities rose 2022.22% to $573,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 271.01%. This contributed to the annual value of $10.6 million for FY2024, which is 13.10% up from last year.
- Per Organogenesis Holdings' latest filing, its Gains from Investment Securities stood at $10.6 million for FY2024, which was up 13.10% from $9.3 million recorded in FY2023.
- In the past 5 years, Organogenesis Holdings' Gains from Investment Securities ranged from a high of $10.6 million in FY2024 and a low of $2.4 million during FY2020.
- Moreover, its 3-year median value for Gains from Investment Securities was $9.3 million (2023), whereas its average is $8.6 million.
- As far as peak fluctuations go, Organogenesis Holdings' Gains from Investment Securities skyrocketed by 171.82% in 2021, and later dropped by 10.08% in 2022.
- Over the past 5 years, Organogenesis Holdings' Gains from Investment Securities (Yearly) stood at $2.4 million in 2020, then spiked by 171.82% to $6.6 million in 2021, then dropped by 10.08% to $5.9 million in 2022, then surged by 57.46% to $9.3 million in 2023, then grew by 13.10% to $10.6 million in 2024.